Frederick T Borts, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 32 Jefferson Ave, Suite 109, Sharon, PA 16146 Phone: 714-981-6732 |
Barry Marchetto, Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 740 E State St, Sharon Regional Health System, Sharon, PA 16146 Phone: 724-981-6732 |
Steven P Karr, MD Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 740 E State St, Sharon, PA 16146 Phone: 724-981-6732 Fax: 724-981-2719 |
News Archive
When a cell divides, its constituents are usually evenly distributed among the daughter cells. UZH researchers have now identified an enzyme that guarantees that cell constituents that are concentrated in organelles without a membrane are properly distributed.
The COVID-19 (coronavirus disease) outbreak has taken nearly 1,900 people and infected more than 73,000 people, mainly in China. It has spread to 28 countries, prompting scientists to develop potential therapies to treat deadly viral infections. Now, Chinese doctors are using plasma therapy to treat coronavirus patients.
We've all been there: Sitting in a consultation with a doctor or nurse, jargon gets thrown around, time with the health-care provider is short and, soon after the conversation concludes, you forget half of what you were told. This can happen whether you're "health literate," meaning you comprehend and feel comfortable with medical terms and concepts, or not, and whether you're a parent dealing with your child's acute sickness or chronic disorder.
BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced its financial results for the first quarter of 2015 and provided a business update.
Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of Central Pennsylvania, as well as a number of angel investors. The funding will be used to accelerate product development and expand clinical support of Saladax's MYCARE™ line of diagnostic tests, which measure blood levels of cancer and Central Nervous System (CNS) disorder drugs, providing physicians with guidance to personalize patient dosing for optimal efficacy.
› Verified 8 days ago